2.02

5.61% -0.12

After Hours: 2.00 -0.02 -0.99%

Hookipa Pharma Inc (HOOK)

Overview News Price History Option Chain Financials Discussions Forecast

Hookipa Pharma Inc stock is traded at $2.02, with a volume of 73,274. It is down -5.61% in the last 24 hours and down -25.74% over the past month. HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies.

Previous Close:

$2.14

Open:

$2.08

24h Volume:

73,274

Relative Volume:

1.43

Market Cap:

$24.35M

Revenue:

$52.16M

Net Income/Loss:

$-48.60M

P/E Ratio:

-2.2198

EPS:

-0.91

Net Cash Flow:

$-77.48M

1W Performance:

-5.16%

1M Performance:

-25.74%

6M Performance:

-69.25%

1Y Performance:

-64.25%

1-Day Range:

$2.00

$2.14

1-Week Range:

$1.9601

$2.27

52-Week Range:

$1.88

$11.30

Hookipa Pharma Inc Stock (HOOK) Company Profile

Name

Hookipa Pharma Inc

Sector

Healthcare (1176)

Industry

Biotechnology (673)

Phone

0114318906360

Address

350 FIFTH AVENUE, 72ND FLOOR, SUITE 7240, NEW YORK, NY

Employee

124

Twitter

@HookipaPharma

Next Earnings Date

2024-11-07

Latest SEC Filings

HOOK's Discussions on Twitter

Compare HOOK with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
HOOK Hookipa Pharma Inc	2.02	24.35M	52.16M	-48.60M	-77.48M	-4.32
VRTX Vertex Pharmaceuticals Inc	397.27	102.31B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	701.85	77.13B	13.85B	4.65B	3.32B	40.41
ARGX Argen X Se Adr	623.82	37.30B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	245.44	31.66B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	113.08	27.11B	3.30B	-501.07M	1.03B	-2.1146

Hookipa Pharma Inc Stock (HOOK) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-15-24	Reiterated	RBC Capital Mkts	Outperform
Dec-02-22	Downgrade	BofA Securities	Buy → Underperform
Nov-12-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Apr-08-21	Initiated	Morgan Stanley	Overweight
Nov-03-20	Initiated	Truist	Buy
Oct-26-20	Initiated	JMP Securities	Mkt Outperform
Oct-19-20	Resumed	H.C. Wainwright	Buy
Sep-27-19	Initiated	H.C. Wainwright	Buy
May-13-19	Initiated	BofA/Merrill	Buy
May-13-19	Initiated	RBC Capital Mkts	Outperform

View All

Hookipa Pharma Inc Stock (HOOK) Latest News

07:14 AM

The Market Doesn't Like What It Sees From HOOKIPA Pharma Inc.'s (NASDAQ:HOOK) Revenues Yet As Shares Tumble 26% - Simply Wall St

07:14 AM

Dec 20, 2024

RBC downgrades HOOKIPA Pharma stock to Sector Perform as restructuring resets pipeline to preclinical - Investing.com

Dec 20, 2024

Dec 16, 2024

HOOKIPA Pharma's SWOT analysis: stock faces challenges amid pipeline shifts By Investing.com - Investing.com South Africa

Dec 16, 2024

Fmr LLC Has $1.47 Million Holdings in Hookipa Pharma Inc (NASDAQ:HOOK) - Defense World

Dec 16, 2024

Dec 15, 2024

HOOKIPA Pharma's SWOT analysis: stock faces challenges amid pipeline shifts - Investing.com

Dec 15, 2024

Dec 13, 2024

Hookipa Pharma stock hits 52-week low at $2.07 amid market challenges - Investing.com

Dec 13, 2024

Dec 04, 2024

JMP Securities Has Lowered Expectations for Hookipa Pharma (NASDAQ:HOOK) Stock Price - Defense World

Nov 25, 2024

Nov 22, 2024

Hookipa Pharma price target lowered to $7 from $24 at JMP Securities - Yahoo Finance

Nov 22, 2024

Hookipa Pharma announces workforce reduction of 80%, pause of eseba-vec program - Yahoo Finance

Nov 22, 2024

Hookipa Pharma stock hits 52-week low at $2.62 amid market challenges - Investing.com Canada

Nov 22, 2024

Hookipa Pharma stock hits 52-week low at $2.62 amid market challenges By Investing.com - Investing.com South Africa

Nov 22, 2024

Nov 19, 2024

Companies Like HOOKIPA Pharma (NASDAQ:HOOK) Could Be Quite Risky - Simply Wall St

Nov 19, 2024

Nov 17, 2024

HOOKIPA Pharma Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance

Nov 17, 2024

Nov 15, 2024

HOOKIPA Pharma stock target lowered, maintains outlook on strategic direction - Investing.com

Nov 15, 2024

RBC Capital Mkts reiterated coverage on HOOKIPA Pharma with a new price target - Quantisnow

Nov 15, 2024